Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Merck Serono brings electronic MS device to six more countries

RebiSmart works alongside the company's MSdialog web-based software
RebiSmart_Merck_Serono

Merck Serono has launched its RebiSmart self-injection device for patients with multiple sclerosis (MS) in six more countries.

The device will now be available in Spain, Greece, Hungary, Israel, Chile and Colombia, following initial launches in 14 countries in May.

Dr Steven Hildemann, chief medical officer and head of global medical affairs and global drug safety at Merck Serono, said: “With the introduction of MSdialog, we are offering a unique digital technology to provide people with MS a management system that can help them create a more open dialogue with their healthcare team.

After using the device to inject themselves RebiSmart is docked and wirelessly send treatment data such as injection times and doses to the MSdialog server.

The MSdialog system can also be used to prompt patients, via email or text message reminders, to take their medication and it periodically sends out health report questionnaires for patients to answer.

Merck's original RebiSmart was the first injection device in MS to record the date, time and dosage of injections to help healthcare professionals monitor patient adherence.

The device was first launched in countries including Germany, France, the UK and Sweden in May and Merck Serono will continue rolling it out during 2015.

19th November 2014

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics